EP0268590A1 - Injection ingress - Google Patents

Injection ingress

Info

Publication number
EP0268590A1
EP0268590A1 EP86905459A EP86905459A EP0268590A1 EP 0268590 A1 EP0268590 A1 EP 0268590A1 EP 86905459 A EP86905459 A EP 86905459A EP 86905459 A EP86905459 A EP 86905459A EP 0268590 A1 EP0268590 A1 EP 0268590A1
Authority
EP
European Patent Office
Prior art keywords
enlarged portion
tube
injection
disc
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP86905459A
Other languages
German (de)
French (fr)
Inventor
Carin Arvidsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0268590A1 publication Critical patent/EP0268590A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02Access sites
    • A61M39/0247Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02Access sites
    • A61M39/0247Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
    • A61M2039/0258Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body for vascular access, e.g. blood stream access
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02Access sites
    • A61M39/0247Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
    • A61M2039/027Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body having a particular valve, seal or septum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02Access sites
    • A61M39/0247Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
    • A61M2039/0276Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body for introducing or removing fluids into or out of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02Access sites
    • A61M39/0247Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
    • A61M2039/0282Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body with implanted tubes connected to the port

Definitions

  • the present invention relates to an injection ingress in ⁇ tended for substantially permanent transplant or at least long-term implanting into the body tissue of a patient, said injection ingress comprising a means protruding into the body tissue or a blood vessel and being provided with a channel for supplying an injection agent to the body tissue.
  • this method of injection using conventional syringe has the advantage that the quantity of agent to be injected can be accurately measured.
  • the object of the present invention is to achieve an injec ⁇ tion ingress of the type described in the introduction, which is designed to completely eliminate the drawbacks of conventional hypodermic syringes or needles without jeopar- . dizing precision in measuring' he quantity of agent to be injected.
  • the object of the invention is thus to effect an injection ingress, the use of which does not inflict pain or other discomfort and which is designed in such a manner that the patient himself can perform the injection, even if his hand is shaky or he has impaired vision, or is even blind.
  • the basic aim of the invention is achieved by an injection ingress wherein the supply means is provided at one end with an enlarged portion having a reception space in commu- nication with the channel, said space being designed to take the point of a hypodermic syringe, wherein the enlarged portion is provided with a positioning means to secure the arrangement to the patient's skin, and wherein the enlarged portion is provided with a valve member through which the point of the syringe can be inserted into the reception space.
  • the supply member is in the form of a thin, flexible tube of material compatible with the body tissue, the enlarged portion being designed to be located mostly below the surface of the skin and consisting of or provided with a surface layer or a surface treatment to facilitate its growth into the skin.
  • the object of the invention is preferably also characterised in that the tube and the enlarged portion are composed of the same material and the side wall of the tube is perfora- ted.
  • Figure 1 shows a section through a portion of tissue on a patient, with a first embodiment of the invention applied
  • FIG. 2 shows a modified embodiment of the invention in a view corresponding to Figure 1
  • Figure 3 shows a longitudinal cross section through the object of the invention in a first, preferred embodiment
  • Figure 4 shows a second embodiment of the invention in a view corresponding to Figure 3
  • Figure 5 shows a third embodiment of the invention in a view corresponding to Figure 3.
  • Figure 1 shows a section through the body tissue 2 and skin 1 of a patient.
  • a first embodiment of the invention is implantated in an outer part of the body tissue. It can be seen that the invention comprises a supply means or tube 3, embedded in the body tissue 2 of the patient and having a suitable length, often 1 - 2 cm, for the purpose. This tube may, of course, terminate in a blood vessel instead.
  • the supply means or the tube may be perforated along the side wall. This is indicated in Figure 1 by small dots.
  • the free end 4 may be made narrower or be entirely closed to the longitudinal inner channel through which the medicament is supplied.
  • Figure 1 also shows that the supply means 3 is provided at the end towards the -skin 2 with an enlarged portion 5, the purpose and construction of which will be described in more detail in the following.
  • the enlarged portion 5 is prefer ⁇ ably provided with a collar 6 or shoulder against which rests a disc 7 of a flexibly, or possible hard material.
  • An attachment part 8 is provided on the outside of the disc 7, continuing from the enlarged portion 5. This part prevents the disc from becoming detached from the enlarged portion and, as will be described below, also has certain functions with respect to the valve member which is located internally in the enlarged portion, in connection with the attachment part.
  • a valve member is arranged in connection with the attachment part 8 and is so designed as to allow the point of a conventional hypodermic syringe to pass through it, thus allowing the point of this needle to enter a reception space in the interior of the enlarged portion 5.
  • a narrow channel then leads from this reception space out to the supply means and the tube.
  • valve member at the attachment member 8 is removed, thus forming an axially directed aperture through the entire device, into which a needle is inserted, the point extend- ing past the free end 4 of the tube 3.
  • a hole is .pricked in the patient's skin and in the tissue 2 below, after which the device is pressed into the hole so that the disc 7 rests on the skin 1.
  • the disc 7 is then secured with sticking plaster, adhesive or in some other suitable manner.
  • the needle is withdrawn to expose the channel running axial ⁇ ly through the device and the valve member and attachment part 8 are then applied.
  • the second method entails enclosing the device in a hard casing of material which will be dissolved by the body and • thus disappear.
  • the casing is tubular in shape, to take the tube 3, and has a sharp point at the end.
  • the procedure for securing the disc 7 is the same as that described above but in this case the valve member need not subsequently be fitted.
  • Figure 3 shows a longitudinal section through the embodiment of the invention described in Figure 1. It can be seen that the enlarged portion 5 has an axially drilled bore 9 which also constitutes the reception space. A longitudinal channel 10 leads from the lower end of this bore 9 to the open end of the tube 3. It can also be seen that the enlarged portion is provided with shoulders 6 in contact with the disc 7, which in turn is held in position by the attachment part 8.
  • the attachment part is in the form of a threaded nut, preferably made of metal or plastic.
  • an insert 11 is used in the enlarged portion 5.
  • This insert is suitably made of en ⁇ tirely rigid material such as hard plastic, metal or the like, and must be selected ensuring that it will not be affected either by the medicament to be injected through the device or by body tissue or liquid produced thereby.
  • the insert 11 is entirely enclosed in the enlarged portion 5 except for an annular neck 12 with external threading to correspond with the threading on the attachment part or nut 8.
  • the disc 7 has an opening into which is fitted a part 14 surrounding the in ⁇ sert 11, this surrounding part having a radially external defining wall which cooperates with the opening, correspond- ing in shape, in the disc 7.
  • the disc is thus prevented from rotating in relation* to the enlarged portion 5.
  • the sur ⁇ rounding part " 14 is of- course composed of the same material, inert with respect to the body, as the tube 3 and enlarged portion 5.
  • the surface of the surrounding part 14 which co- operates with the disc 7 may be rectangular or polygon in order to achieve reliable engagement with the disc 7, pre ⁇ venting rotation thereof.
  • valve member con ⁇ sists of a disc 15 of resilient material which is com- pressed by the nut 8 in a recess 16 in the insert 11.
  • the disc 15 is compressed and made of a resilient material to facilitate penetration by the point of an injection needle without any permanent opening remaining in the disc when the needle has been withdrawn.
  • the valve member will there- fore be completely self-sealing and form a perfect seal as long as it has not been penetrated too often.
  • the disc 15 can be replaced by simply unscrewing the nut 8, removing the disc from the recess 16 in the insert 11 and replacing it by a new one. The attachment member or nut 8 is then screwed back into place.
  • Figure 3 also shows that all surfaces of the device designed to be implanted in the skin or in the tissue below the skin of the patient consist of the same material as the tube 3 and enlarged portion 5.
  • the small part 12 of the insert 11, to which the nut 8 is screwed is located outside the disc 7 and is therefore without significance insofar as contact with the body is concerned.
  • Figure 2 shows a modified embodiment of the invention accord ing to Figure 1.
  • the most significant difference here is tha the longitudinal direction of the supply means or tube 3 and the enlarged portion 5 is located at an angle to the plane of the disc 7.
  • An internal, longitudinal channel through the device according to the invention is thus also used in this embodiment, as well as a self-sealing valve in conjunction with the attachment member 8.
  • the enlarged por- tion 5 with the reception space 9 is located partially out ⁇ side the skin 1. It is of course possible to go one step further and locate this entirely outside the skin if de ⁇ sired.
  • an insert 17 of substantially solid material is used, such as hard plastic or metal.
  • the insert 17 fits into a corresponding recess 18 in a tubular section 19 of the end of the enlarged portion 5 opposite to the tube 3.
  • a peripheral groove with conical sur ⁇ face 21 Between the tubular section 19 and the shoulder 6 for abutment against the disc 7 is a peripheral groove with conical sur ⁇ face 21, the groove expanding in axial direction away from the disc 7.
  • the insert 17 is also provided with a corres ⁇ ponding conical surface 22, approximately parallel to the conical surface 21 of the groove 20.
  • the insert 17 is provided with a shallow recess to hold the actual valve member or disc 15, this also consisting of resilient material under pressure.
  • the pressure loading is effected in this embodiment by a ring 23, slotted in axial direction, made of a permanently deformable material such as metal and having an inwardly directed portion 24 at the end facing the disc 7, the portion 24 being approximately complementary to the groove 20.
  • the inwardly directed por- tion 24 of the ring 23 will abut against the disc 7, secur ⁇ ing this in position against the shoulder 6.
  • the end of the en ⁇ larged portion 5 facing away from the disc 7 is provided with a recess surrounded by a curved wall 25 and having substantially conical bottom 26.
  • a ring 27 is arranged radially outside the curved wall 25 to prevent radial expan ⁇ sion and deformation of the curved wall.
  • This ring prefer ⁇ ably consists of hard plastic or metal and is provided externally with a peripheral groove for a locking ring 28 to lock the disc 7 in- relation to the ring 27.
  • valve member comprises a substantial ⁇ ly circular disc 15 which is pressed down into the space defined by the curved wall 25 and the conical bottom 26 of the recess in the end of the enlarged portion 5 facing away from the tube 3.
  • This disc 15 is inserted through an opening 29 extending through both the ring 27 and the curved wall 25.
  • the dimensions are selected so that during compression the disc 15 must be pressed to the position shown in the drawing where it is retained in compressed state, bulging slightly towards the conical bottom surface 26 and reception space 9.
  • the enlarged portion 5 will not be completely rigid, but deformable, so that it too can adjust to movements in the skin and tissue below the skin.
  • the material for the disc 7 should of course be substantially rigid and stable in shape. However, it should not be so hard as to cause discomfort to the user. Naturally the disc mate ⁇ rial should be of a quality which will not cause allergy or skin irritation.
  • the tube 3 has been shown in all the drawings as relatively short and approximately uniform in thickness. Obviously, the tube 3 may be considerably longer and its cross section may vary, it being thicker close to the enlarged portion 5 than at the free end 4, for instance.
  • a tube of this design may be suitable for supplying drugs to internal organs or the like.
  • the side wall of the tube 3 may suitably be perforated, thus increasing the absorption area for the drug injected.
  • an unperforated tube may also be used, and is necessary if a drug is to be accurately supplied to a specific area.
  • both the tube and the enlarged portion 5 may be made of a silicon rubber, in which case they can be manufactured in one piece by an injection moulding pro ⁇ cess or by joining the enlarged portion 5 to an extruded tube, the join being effected by glueing or vulcanization. It might also be possible to make the enlarged portion of different material, such as metals like titanium or certain stainless steel alloys, for instance, the tube 3 then being glued into the enlarged portion. In this case it may be advisable to make the tube 3 thicker at the joint with the enlarged portion to prevent damage in this area. Certain grades of polythene may also be used as an alterna ⁇ tive to the above-mentioned silicon material for the tube 3 and enlarged portion 5.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Point d'accès pour pratiquer une injection, avec un organe d'administration (3) pourvu d'un canal (10) faisant saillie dans les tissus corporels d'un patient afin d'administrer un agent d'injection ou tissu corporel ou à un vaisseau sanguin. L'organe d'administration (3) est muni à une extrémité d'une partie élargie (5) possédant un espace de réception (9) communiquant avec le canal (10), ledit espace étant destiné à recevoir la pointe d'une seringue hypodermique. La partie élargie est pourvue d'un organe de positionnement (7) permettant de fixer l'agencement à la peau (1) du patient, et d'un organe à soupape (15) par l'intermédiaire duquel la pointe de la seringue peut être introduite dans l'espace de réception.Access point for injecting, with an administration member (3) provided with a channel (10) projecting into the body tissues of a patient in order to administer an injection agent or body tissue or to a blood vessel. The administration member (3) is provided at one end with an enlarged part (5) having a receiving space (9) communicating with the channel (10), said space being intended to receive the tip of a syringe hypodermic. The enlarged part is provided with a positioning member (7) for fixing the arrangement to the patient's skin (1), and with a valve member (15) by means of which the tip of the syringe can be introduced into the reception area.

Description

INJECTION INGRESS
TECHNICAL FIELD
The present invention relates to an injection ingress in¬ tended for substantially permanent transplant or at least long-term implanting into the body tissue of a patient, said injection ingress comprising a means protruding into the body tissue or a blood vessel and being provided with a channel for supplying an injection agent to the body tissue.
BACKGROUND OF THE INVENTION
In the case of diseases requiring the repeated supply of the type of drug which is injected into the body tissue, this has previously been effected with the aid of a con¬ ventional hypodermic syringe which is simply inserted into the "body tissue at a suitable point, whereafter the contents of the syringe is emptied and the syringe then withdrawn. This method entails considerable drawbacks, particularly if the drug must be administered frequently, primarily because the risk of infection and the formation of scars can never be avoided.
However, this method of injection using conventional syringe has the advantage that the quantity of agent to be injected can be accurately measured.
In this connection it should also be mentioned that some patients are hardly capable of effecting the necessary in- jection in conventional manner or dare not. A considerable amount of time is thus demanded on the part of nursing staff for this purpose, not to mention the discomfort and pain ' inflicted by such injections. When injecting drugs into a blood vessel on repeated occasions, a needle made of a hard material, usually metal, is normally used. This is inserted into the blood vessel and held in position by an adhesive plaster or the like adhering to the "patient' s skin.
The greatest drawback with this procedure is that the needle must be frequently changed and that it causes both irrita¬ tion and direct pain.
OBJECT OF THE INVENTION
The object of the present invention is to achieve an injec¬ tion ingress of the type described in the introduction, which is designed to completely eliminate the drawbacks of conventional hypodermic syringes or needles without jeopar- . dizing precision in measuring' he quantity of agent to be injected. The object of the invention is thus to effect an injection ingress, the use of which does not inflict pain or other discomfort and which is designed in such a manner that the patient himself can perform the injection, even if his hand is shaky or he has impaired vision, or is even blind.
SUMMARY OF THE INVENTION
The basic aim of the invention is achieved by an injection ingress wherein the supply means is provided at one end with an enlarged portion having a reception space in commu- nication with the channel, said space being designed to take the point of a hypodermic syringe, wherein the enlarged portion is provided with a positioning means to secure the arrangement to the patient's skin, and wherein the enlarged portion is provided with a valve member through which the point of the syringe can be inserted into the reception space.
in order to eliminate the risk of tissue damage and skin irritation, but also to reduce any problems associated with the use of the device to an absolute minimum, according to the invention the supply member is in the form of a thin, flexible tube of material compatible with the body tissue, the enlarged portion being designed to be located mostly below the surface of the skin and consisting of or provided with a surface layer or a surface treatment to facilitate its growth into the skin.
These features offer the great advantage that the supply member is able to move together with the surrounding tissue and also that the enlarged portion is able to become pro- perly secured in the skin, possibly even becoming perma-. nently embedded.
The object of the invention is preferably also characterised in that the tube and the enlarged portion are composed of the same material and the side wall of the tube is perfora- ted.
These features offer both manufacturing advantages and the great medical advantage of increased absorption area for the injection agent in the body tissue, thus reducing the risk of tissue damage as well as improving the absorption rate for the injection agent.
Additional advantages are achieved according to the inven¬ tion, if the object of the invention is given one or more of the features defined in claims 4 - 7. BRIEF DESCRIPTION OF THE DRAWINGS
The invention will now be described in more detail with reference to the accompanying drawings, in which
Figure 1 shows a section through a portion of tissue on a patient, with a first embodiment of the invention applied,
Figure 2 shows a modified embodiment of the invention in a view corresponding to Figure 1,
Figure 3 shows a longitudinal cross section through the object of the invention in a first, preferred embodiment,
Figure 4 shows a second embodiment of the invention in a view corresponding to Figure 3, and
Figure 5 shows a third embodiment of the invention in a view corresponding to Figure 3.
DESCRIPTION OF SPECIFIC EMBODIMENTS
Figure 1 shows a section through the body tissue 2 and skin 1 of a patient. A first embodiment of the invention is implantated in an outer part of the body tissue. It can be seen that the invention comprises a supply means or tube 3, embedded in the body tissue 2 of the patient and having a suitable length, often 1 - 2 cm, for the purpose. This tube may, of course, terminate in a blood vessel instead.
To increase the area of tissue 2 able to absorb the drug supplied from the means 3, the supply means or the tube may be perforated along the side wall. This is indicated in Figure 1 by small dots. To further improve penetration of the injection agent through the perforations in the side wall of the tube, the free end 4 may be made narrower or be entirely closed to the longitudinal inner channel through which the medicament is supplied.
Figure 1 also shows that the supply means 3 is provided at the end towards the -skin 2 with an enlarged portion 5, the purpose and construction of which will be described in more detail in the following. The enlarged portion 5 is prefer¬ ably provided with a collar 6 or shoulder against which rests a disc 7 of a flexibly, or possible hard material. An attachment part 8 is provided on the outside of the disc 7, continuing from the enlarged portion 5. This part prevents the disc from becoming detached from the enlarged portion and, as will be described below, also has certain functions with respect to the valve member which is located internally in the enlarged portion, in connection with the attachment part.
As implied above, a valve member is arranged in connection with the attachment part 8 and is so designed as to allow the point of a conventional hypodermic syringe to pass through it, thus allowing the point of this needle to enter a reception space in the interior of the enlarged portion 5. A narrow channel then leads from this reception space out to the supply means and the tube. It should be mentioned that the volume in this channel and the volume in the re¬ ception space should be as small as possible in order to ensure accuracy of the quantity of medicament to be injected via the object of the invention.
In principle two different methods may be used to apply the device according to the invention. In the first case the valve member at the attachment member 8 is removed, thus forming an axially directed aperture through the entire device, into which a needle is inserted, the point extend- ing past the free end 4 of the tube 3. With the aid of this needle a hole is .pricked in the patient's skin and in the tissue 2 below, after which the device is pressed into the hole so that the disc 7 rests on the skin 1. The disc 7 is then secured with sticking plaster, adhesive or in some other suitable manner. When the disc 7 has been secured, the needle is withdrawn to expose the channel running axial¬ ly through the device and the valve member and attachment part 8 are then applied.
The second method entails enclosing the device in a hard casing of material which will be dissolved by the body and thus disappear. To enable insertion through the skin 1 and in into the tissue below, the casing is tubular in shape, to take the tube 3, and has a sharp point at the end. The procedure for securing the disc 7 is the same as that described above but in this case the valve member need not subsequently be fitted.
Figure 3 shows a longitudinal section through the embodiment of the invention described in Figure 1. It can be seen that the enlarged portion 5 has an axially drilled bore 9 which also constitutes the reception space. A longitudinal channel 10 leads from the lower end of this bore 9 to the open end of the tube 3. It can also be seen that the enlarged portion is provided with shoulders 6 in contact with the disc 7, which in turn is held in position by the attachment part 8. In this embodiment the attachment part is in the form of a threaded nut, preferably made of metal or plastic. In the embodiment shown in Figure 3 an insert 11 is used in the enlarged portion 5. This insert is suitably made of en¬ tirely rigid material such as hard plastic, metal or the like, and must be selected ensuring that it will not be affected either by the medicament to be injected through the device or by body tissue or liquid produced thereby. The insert 11 is entirely enclosed in the enlarged portion 5 except for an annular neck 12 with external threading to correspond with the threading on the attachment part or nut 8.
From the drawings it can be seen that the disc 7 has an opening into which is fitted a part 14 surrounding the in¬ sert 11, this surrounding part having a radially external defining wall which cooperates with the opening, correspond- ing in shape, in the disc 7. The disc is thus prevented from rotating in relation* to the enlarged portion 5. The sur¬ rounding part" 14 is of- course composed of the same material, inert with respect to the body, as the tube 3 and enlarged portion 5. The surface of the surrounding part 14 which co- operates with the disc 7 may be rectangular or polygon in order to achieve reliable engagement with the disc 7, pre¬ venting rotation thereof.
In the embodiment shown in Figure 3 the valve member con¬ sists of a disc 15 of resilient material which is com- pressed by the nut 8 in a recess 16 in the insert 11. The disc 15 is compressed and made of a resilient material to facilitate penetration by the point of an injection needle without any permanent opening remaining in the disc when the needle has been withdrawn. The valve member will there- fore be completely self-sealing and form a perfect seal as long as it has not been penetrated too often. The disc 15 can be replaced by simply unscrewing the nut 8, removing the disc from the recess 16 in the insert 11 and replacing it by a new one. The attachment member or nut 8 is then screwed back into place. It should be pointed out that the insert 11 and the enlarged portion 5 connected therewith are prevented from rotating due to their engage¬ ment with the disc 7 and its adhesion to the skin. Figure 3 also shows that all surfaces of the device designed to be implanted in the skin or in the tissue below the skin of the patient consist of the same material as the tube 3 and enlarged portion 5. The small part 12 of the insert 11, to which the nut 8 is screwed is located outside the disc 7 and is therefore without significance insofar as contact with the body is concerned.
DESCRIPTION OF MODIFIED EMBODIMENTS
Figure 2 shows a modified embodiment of the invention accord ing to Figure 1. The most significant difference here is tha the longitudinal direction of the supply means or tube 3 and the enlarged portion 5 is located at an angle to the plane of the disc 7. An internal, longitudinal channel through the device according to the invention is thus also used in this embodiment, as well as a self-sealing valve in conjunction with the attachment member 8.
In the embodiment according to Figure 2, the enlarged por- tion 5 with the reception space 9 is located partially out¬ side the skin 1. It is of course possible to go one step further and locate this entirely outside the skin if de¬ sired.
The embodiment according to Figure 4 has certain features in common with that according to Figure 3. In this embodiment, too, an insert 17 of substantially solid material is used, such as hard plastic or metal. The insert 17 fits into a corresponding recess 18 in a tubular section 19 of the end of the enlarged portion 5 opposite to the tube 3. Between the tubular section 19 and the shoulder 6 for abutment against the disc 7 is a peripheral groove with conical sur¬ face 21, the groove expanding in axial direction away from the disc 7. The insert 17 is also provided with a corres¬ ponding conical surface 22, approximately parallel to the conical surface 21 of the groove 20.
Furthermore, at the end facing away from the disc 7, the insert 17 is provided with a shallow recess to hold the actual valve member or disc 15, this also consisting of resilient material under pressure. The pressure loading is effected in this embodiment by a ring 23, slotted in axial direction, made of a permanently deformable material such as metal and having an inwardly directed portion 24 at the end facing the disc 7, the portion 24 being approximately complementary to the groove 20.
When the ring 23, somewhat expanded in circumferential di¬ rection, is passed over the tubular portion 19 and there¬ after clamped by means of a tong or similar tool, the in¬ wardly directed portion 24 will be taken up in the groove 20 and will compress the material in the enlarged portion 5, thus pressing the insert 17 away from the disc 7. The in¬ sert 17 will thus exert axial pressure on the disc 15 bring¬ ing it into abutment with the inside end surface of the slotted ring 23.
It can be seen from Figure 4 that the inwardly directed por- tion 24 of the ring 23 will abut against the disc 7, secur¬ ing this in position against the shoulder 6. In the embodiment according to Figure 5 the end of the en¬ larged portion 5 facing away from the disc 7 is provided with a recess surrounded by a curved wall 25 and having substantially conical bottom 26. A ring 27 is arranged radially outside the curved wall 25 to prevent radial expan¬ sion and deformation of the curved wall. This ring prefer¬ ably consists of hard plastic or metal and is provided externally with a peripheral groove for a locking ring 28 to lock the disc 7 in- relation to the ring 27.
In this embodiment the valve member comprises a substantial¬ ly circular disc 15 which is pressed down into the space defined by the curved wall 25 and the conical bottom 26 of the recess in the end of the enlarged portion 5 facing away from the tube 3. This disc 15 is inserted through an opening 29 extending through both the ring 27 and the curved wall 25. The dimensions are selected so that during compression the disc 15 must be pressed to the position shown in the drawing where it is retained in compressed state, bulging slightly towards the conical bottom surface 26 and reception space 9.
The material to be used for those parts of the device accord¬ ing to the invention coming into contact with body tissue or skin must be selected with great care. However, it may be mentioned that silicon material of semi-hard or rubberlike consistency has proved extremely suitable for both the en- larged portion 5 and the tube 3. Obviously, due to its slim dimensions (external diameter in the order of 0.5 - 1 mm and inner diameter in the order of 0.1 - 0.5 mm), the tube will be extremely flexible and will therefore follow any movement in the body tissue without causing irritation or discomfort.
Similarly the enlarged portion 5 will not be completely rigid, but deformable, so that it too can adjust to movements in the skin and tissue below the skin.
The material for the disc 7 should of course be substantially rigid and stable in shape. However, it should not be so hard as to cause discomfort to the user. Naturally the disc mate¬ rial should be of a quality which will not cause allergy or skin irritation.
The tube 3 has been shown in all the drawings as relatively short and approximately uniform in thickness. Obviously, the tube 3 may be considerably longer and its cross section may vary, it being thicker close to the enlarged portion 5 than at the free end 4, for instance. A tube of this design may be suitable for supplying drugs to internal organs or the like.
It has been mentioned above that the side wall of the tube 3 may suitably be perforated, thus increasing the absorption area for the drug injected. Obviously an unperforated tube may also be used, and is necessary if a drug is to be accurately supplied to a specific area.
As mentioned above, both the tube and the enlarged portion 5 may be made of a silicon rubber, in which case they can be manufactured in one piece by an injection moulding pro¬ cess or by joining the enlarged portion 5 to an extruded tube, the join being effected by glueing or vulcanization. It might also be possible to make the enlarged portion of different material, such as metals like titanium or certain stainless steel alloys, for instance, the tube 3 then being glued into the enlarged portion. In this case it may be advisable to make the tube 3 thicker at the joint with the enlarged portion to prevent damage in this area. Certain grades of polythene may also be used as an alterna¬ tive to the above-mentioned silicon material for the tube 3 and enlarged portion 5.
The invention can be modified within the scope of the follow¬ ing claims.

Claims

C l a i m s
1. An injection ingress comprising a means (3) protruding into the body tissue (2) of a patient, said means being provided with a channel (10) for supplying an injection agent to the body tissue or to a blood vessel, w h e r e - i n the supply means (3) is provided at one end with an enlarged portion (5) having a reception space (9) in commu¬ nication with the channel (10) , said space being designed to take the point of a hypodermic syringe, wherein the en¬ larged portion is provided with a positioning means (7) to secure the arrangement to the patient's skin, and wherein the enlarged portion is provided with a valve member (15) through which the point of the syringe can be inserted into the reception space.
2. An injection ingress according to claim 1, w h e r e - i n the supply member (3) is in the form of a thin, flexib¬ le tube of material compatible with body tissue, wherein the enlarged portion (5) is designed to be located mostly below the skin (1) and consists of or is provided with a surface layer or a surface treatment to facilitate its growth into the skin.
3. An injection ingress according to claim 2, w h e r e - i n the tube (3) and the enlarged portion (5) are composed of the same material and the side wall of the tube is per¬ forated.
4. An injection ingress according to any of claims 1 - 3, w h e r e i n the longitudinal axis of the enlarged por¬ tion (5) and the tube (3) is approximately perpendicular to the positioning member (7) , which is in the shape of a disc.
5. An injection ingress according to any of claims 1 - 3, w h e r e i the longitudinal axis of the enlarged por¬ tion (5) and the tube (3) forms an acute angle to the posi¬ tioning means (7) , which is in the form of a disc.
6. An injection ingress according to any of claims 1 - 5, w h e r e i n an insert (11, 17) is arranged inside the enlarged portion (5) , said insert consisting of a hard mate¬ rial inert to influence from the injection agent or the body, and forming at least a part of the reception space (9) , the valve member (15) being replaceably secured in this insert.
7. An injection ingress according to claim 6, w h e r e ¬ i n a positioning member (8, 23) for the valve member (15) in the insert (11, 17) is provided to prevent removal of the positioning member (7) from the enlarged portion (5) .
EP86905459A 1985-08-15 1986-08-15 Injection ingress Ceased EP0268590A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8503817A SE453638B (en) 1985-08-15 1985-08-15 INJEKTIONSINGANG
SE8503817 1985-08-15

Publications (1)

Publication Number Publication Date
EP0268590A1 true EP0268590A1 (en) 1988-06-01

Family

ID=20361102

Family Applications (1)

Application Number Title Priority Date Filing Date
EP86905459A Ceased EP0268590A1 (en) 1985-08-15 1986-08-15 Injection ingress

Country Status (7)

Country Link
EP (1) EP0268590A1 (en)
JP (1) JPS63501405A (en)
KR (1) KR870700367A (en)
AU (1) AU6227586A (en)
DK (1) DK192787A (en)
SE (1) SE453638B (en)
WO (1) WO1987001041A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8618253D0 (en) * 1986-07-25 1986-09-03 Wallace Ltd H G Intermittent administration of therapeutic substance
ATE83160T1 (en) * 1987-08-25 1992-12-15 Infusaid Inc IMPLANTABLE DEVICE.
US5092849A (en) * 1987-08-25 1992-03-03 Shiley Infusaid, Inc. Implantable device
EP0323535A1 (en) * 1988-01-05 1989-07-12 Hellige GmbH Adapter for exchangeable implantation of biosensors in the skull bone
US5100392A (en) * 1989-12-08 1992-03-31 Biosynthesis, Inc. Implantable device for administration of drugs or other liquid solutions
FR2749174B1 (en) * 1996-05-30 2000-06-23 Navarro Francis INTERNAL AND EXTERNAL DEVICE FOR DRAINING LIQUID COLLECTIONS AFTER SURGICAL INTERVENTION
US7338465B2 (en) 2002-07-02 2008-03-04 Patton Medical Devices, Lp Infusion device and method thereof
US8029454B2 (en) 2003-11-05 2011-10-04 Baxter International Inc. High convection home hemodialysis/hemofiltration and sorbent system
WO2007056309A2 (en) 2005-11-03 2007-05-18 Patton Medical Devices, Lp Fluid delivery devices, systems and methods
CN111166439A (en) * 2016-03-29 2020-05-19 美敦力公司 A apparatus is kept somewhere to skin table for guiding puncture

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3783868A (en) * 1971-05-06 1974-01-08 Gulf Oil Corp Percutaneous implant
US4488877A (en) * 1982-08-23 1984-12-18 Renal Systems, Inc. Percutaneous implant for peritoneal dialysis
FR2551348B1 (en) * 1983-09-02 1986-08-29 Meriaux Henri INFUSION DEVICE
US4781693A (en) * 1983-09-02 1988-11-01 Minntech Corporation Insulin dispenser for peritoneal cavity

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8701041A1 *

Also Published As

Publication number Publication date
JPS63501405A (en) 1988-06-02
DK192787D0 (en) 1987-04-14
WO1987001041A1 (en) 1987-02-26
SE8503817D0 (en) 1985-08-15
SE8503817L (en) 1987-02-16
DK192787A (en) 1987-04-14
AU6227586A (en) 1987-03-10
KR870700367A (en) 1987-12-28
SE453638B (en) 1988-02-22

Similar Documents

Publication Publication Date Title
US3612050A (en) Intravascular catheters
US4772276A (en) Catheter tube coupling assembly and methods
JP4425546B2 (en) Catheter with low resistance septum
US6375640B1 (en) Winged injection needle device
US4966588A (en) Device suitable for the administration of a therapeutic substance
JP4187922B2 (en) Liquid injection needle and liquid injection device
US4772261A (en) Intramedullary catheter
US6878137B2 (en) Implantable device for injecting medical substances
US5002538A (en) Syringe adapter and method
KR100731312B1 (en) Injection device
JPS61265146A (en) Embeddable apparatus for long-term injection of substance, especially,treating substance
KR20070114721A (en) Gateway system
BRPI0620833A2 (en) Atraumatic implantable medical facility for simplified construction
US8961460B2 (en) Syringe needle assembly and medication injection device
JPS62201159A (en) Flexible cannula type hypodermic injection set and its production
JPH07136284A (en) Freely-implamtable vascular system connecting instrument
US20240033433A1 (en) Syringe-type microneedle
US20120179113A1 (en) Syringe needle assembly and medication syringe device
EP0268590A1 (en) Injection ingress
KR20140137308A (en) Intracerebral drug injection device, the assembly for installing the injection device, and a method for delivering cerebropathy treatment drugs into the human brain
US20040010235A1 (en) Anti-reflux syringe
JPS6359972A (en) Catheter apparatus for embedding
JP2007283132A (en) Liquid injection needle and liquid injector
CN111035439A (en) Nerve block puncture medicine injection device
JPH08107934A (en) Cap for subcutaneous embedment type medicinal liquid injecting port sleeve

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19880212

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19891113

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 19901231